Robert F. Williamson III - 21 Dec 2023 Form 4 Insider Report for Perspective Therapeutics, Inc. (CATX)

Role: Director
Signature: /s/ Robert F. Williamson III
Issuer symbol: CATX
Transactions as of: 21 Dec 2023
Net transactions value: +$1,203
Form type: 4
Filing time: 26 Dec 2023, 17:00:27 UTC
Previous filing: 19 Dec 2023
Next filing: 26 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CATX	Common Stock	Purchase	$1,203	+3,663		$0.3283	3,663	21 Dec 2023	By RFW3 Revocable Trust	F1
holding	CATX	Common Stock						23,680	21 Dec 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.3249 to $0.3300, inclusive. The reporting person undertakes to provide to Perspective Therapeutics, Inc., any security holder of Perspective Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

Content

This price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.3249 to $0.3300, inclusive. The reporting person undertakes to provide to Perspective Therapeutics, Inc., any security holder of Perspective Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.